Close this search box.

Public Companies

Public pharmaceutical companies leverage RNA Advisors for assistance with M&A opportunitiesout licensing of assets, royalty stream evaluations, and strategic partnership decision making. Public or mid-cap biopharma companies seek advisory support from the RNA team for life sciences investments and acquisitions (on the buy-side) as well as analytical and strategic support for due diligence, tax and financial reporting, and decision- making advice around license and asset acquisitions.

Meet some of our public clients:

What Our Clients Say

Sign Up for Periodic Updates

Enter your email address below to receive updates from RNA Advisors.